# [CCND3]

## Mutation tier

|Entity|Tier|
|------|----|
|BL    |1   |
|DLBCL |1   |
|FL    |1   |

## Mutation incidence

|Entity|study                |frequency (%)|
|------|---------------------|-------------|
|BL    |GAMBL genomes+capture|27.48        |
|BL    |Thomas cohort        |28.00        |
|BL    |Panea cohort         |17.80        |
|DLBCL |GAMBL genomes        | 6.80        |
|DLBCL |Schmitz cohort       | 9.80        |
|DLBCL |Reddy cohort         | 3.80        |
|DLBCL |Chapuy cohort        | 4.70        |
|FL    |GAMBL genomes        | 3.23        |

## Mutation pattern

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|------|----|---------------------|----------------|----------------|
|BL    |No  |Yes                  |97.799          |360.774         |
|DLBCL |No  |Yes                  |19.557          | 60.833         |
|FL    |No  |No                   |24.611          |  0.000         |


> [!NOTE]
> First described in BL in 2012 by [Schmitz R](https://pubmed.ncbi.nlm.nih.gov/22885699). First described in DLBCL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119). First described in FL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119)